This month, Insights & Outcomes dives into some new dopamine research, looks at how to build a better flu vaccine, and celebrates Yale’s inclusion on a committee advising the federal government on quantum information science.
As always, you can find...
Yale scientists have discovered an underlying mechanism for Fragile X syndrome — a leading cause of autism and the primary genetic driver of intellectual disability — as well as a drug that reversed the underlying abnormality and autism-like behaviors in...
Three Yale researchers are among 30 pairs of scientists awarded grants to study the molecular origins of neurodegenerative diseases, the Chan Zuckerberg Initiative announced Aug. 19.
The $4.5 million initiative is designed to foster collaborations between...
A mosquito species that is one of the world’s leading killers of humans arose more than 7 million years ago on islands in the Indian Ocean, some of which had no mammals of any kind, according to a genetic analysis by Yale researchers published August 17...
Sarecycline, a drug approved for use in the United States in 2018, is the first new antibiotic approved to treat acne in more than 40 years. Now, researchers at Yale and the University of Illinois-Chicago have discovered how its unique chemical structure...
This month, Insights & Outcomes will turn your head with spinning electrons, prolific plankton, and the biology of sex.
As always, you can find more science and medicine research news on YaleNews’ Science & Technology and Health & Medicine ...
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
Known as LAM-002A (apilimod), the drug has a proven safety record. Preliminary research has shown it...
In the fight against pathogens, most researchers have focused on the diverse immune system arsenal that protects people against infection. However, the lab of Yale microbiologist Jorge Galan explored an evolutionarily ancient defense system possessed by...